tirzepatide dose equivalent to semaglutide Dose-equivalence reference based on pivotal GLP-1/dual-agonist trials: SURMOUNT-1 (tirzepatide/Zepbound, 72 weeks) STEP-1 (subcutaneous semaglutide/Wegovy, 68 weeks) OASIS-4 (oral semaglutide/Wegovy, 64 weeks). For educational comparison only—these are tirzepatide semaglutide dose conversion dosing

[1] [4] It belongs to a class of medications known as glucagon-like peptide-1 (GLP-1) receptor agonists

Wegovy pill: first oral GLP-1 approved for weight loss In a landmark development, the FDA approved the Wegovy pill (oral semaglutide 25 mg) on December 22, 2025 , making it the worlds first oral GLP-1 receptor agonist approved specifically for weight management a major shift from the injection-only landscape [8]

How to Book Your Wegovy Consultation at Pure Medical Spa Getting started is simple and confidential

Palodetto B et al

A thin wand is inserted into the skin, delivering a stream of helium plasma and RF energy to the tissue